Enjoy complimentary customisation on priority with our Enterprise License!
The proton therapy market size is estimated to grow by USD 442.1 million at a CAGR of 8.51% between 2023 and 2028. Proton therapy is a cutting-edge cancer treatment technology that utilizes protons instead of traditional X-rays for radiation therapy. With the increasing prevalence of various types of cancers worldwide, the demand for advanced and effective cancer treatments has grown significantly. Proton therapy offers several advantages over standard radiation therapies, including reduced side effects, improved precision, and greater depth of penetration. As a result, the number of proton therapy patients has been steadily increasing. In response to this growing demand, the number of proton therapy treatment rooms and centers is also on the rise. These centers provide patients with access to this innovative treatment option, offering hope and improved outcomes for those battling cancer.
For More Highlights About this Report, Request Free Sample
Proton therapy is a specialized form of radiation therapy that utilizes proton particles instead of photons to treat cancer. This type of therapy is gaining popularity due to its ability to precisely target tumors while minimizing damage to healthy tissues. Proton therapy is particularly effective for treating pediatric cancers and certain types of CNS cancer. The Market is expected to grow significantly due to increasing awareness of the benefits of this therapy and advancements in technology. The market is driven by the rising prevalence of cancer, especially pediatric cancers, and the need to reduce the side effects of traditional radiation therapy. Proton therapy devices use pencil beam scanning technology to deliver protons to cancerous cells with high precision. This reduces the risk of long-term complications compared to photon therapy and other forms of particle therapy. However, the high cost of proton therapy devices and the complexity of the treatment process are major challenges to market growth.
Clinical data shows that proton therapy is effective in treating various types of tumors, including those caused by cancer-causing viruses and faulty genes. The market is expected to be influenced by ongoing research and development in the field, as well as awareness campaigns aimed at increasing the use of proton therapy in cancer treatment. Despite its advantages, proton therapy is not without risks. The treatment process requires precise set-up and delivery of proton particles, and there is a risk of damage to healthy tissues, especially in the case of CNS cancer. Long-term complications are also a concern, and more clinical data is needed to fully understand the risks and benefits of proton therapy. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing prevalence of cancers is notably driving market growth. The global incidence of chronic disorders, particularly cancer, is on the rise, with an estimated 21.3 million new cases anticipated between 2017 and 2025. The top five leading cancer disorders diagnosed in 2020 were lung cancer, breast cancer, colorectal cancer, prostate cancer, and stomach cancer, collectively accounting for approximately 49% of all diagnosed cases. Lung cancer and breast cancer accounted for the largest number of diagnosed cases.
Furthermore, the associated risk factors of these disorders continue to increase, necessitating advanced treatment modalities. Precision treatments, such as Proton Therapy, have gained significant attention due to their ability to deliver high doses of radiation to the tumor site while minimizing exposure to healthy surrounding tissue. Government support and the expansion of healthcare facilities are expected to boost the growth of the Proton Therapy Market in the coming years. Thus, such factors are driving the growth of the market during the forecast period.
Technological advances is the key trend in the market. The global proton therapy market is experiencing notable growth due to the increasing prevalence of chronic disorders, particularly cancer. Advanced technologies, such as Passive Scattering (PBS) proton therapy, are gaining significant attention in the field. PBS delivers proton beams with increased precision, minimizing radiation exposure to healthy tissues. This is particularly crucial in pediatric cancer treatment, where reducing side effects is of utmost importance. Improvements in imaging technologies, including CT, MRI, and PET, enable more accurate tumor detection, even in hard-to-reach areas of the body. Government support and expansion of healthcare facilities are further driving the market's growth. Proton therapy's ability to offer more targeted treatments with fewer side effects is expected to fuel its adoption, making it a promising modality in cancer care.
Technological advances is the key trend in the market. The market is experiencing notable growth due to the increasing prevalence of chronic disorders, particularly cancer. Advanced technologies, such as Passive Scattering (PBS) proton therapy, are gaining significant attention in the field. PBS delivers proton beams with increased precision, minimizing radiation exposure to healthy tissues.
Furthermore, this is particularly crucial in pediatric cancer treatment, where reducing side effects is of utmost importance. Improvements in imaging technologies, including CT, MRI, and PET, enable more accurate tumor detection, even in hard-to-reach areas of the body. Government support and expansion of healthcare facilities are further driving the market's growth. Proton therapy's ability to offer more targeted treatments with fewer side effects is expected to fuel its adoption, making it a promising modality in cancer care. Thus, such trends will shape the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Hitachi Ltd. - The company offers proton therapy system namely Probeat Series.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The equipment segment is estimated to witness significant growth during the forecast period. Proton therapy is a type of radiation therapy that utilizes high-energy proton particles to destroy cancerous cells with precision. This advanced form of particle therapy offers several advantages over traditional photon therapy, such as minimizing damage to healthy tissues and reducing long-term complications. Proton therapy devices consist of an accelerator, beam transport system, beam delivery system, nozzle & image viewers, patient positioning system, and set-up systems.
Get a glance at the market share of various regions Download the PDF Sample
The equipment segment was the largest segment and was valued at USD 560.40 million in 2018. Physicians often recommend proton therapy for various types of cancers, including prostate, breast, CNS, and pediatric cancers. The precision dose delivered by proton therapy minimizes the risk of side effects, such as those caused by cancer-causing viruses and faulty genes. Proton therapy centers have become increasingly common in hospitals, providing patient access to this innovative cancer treatment. Proton therapy works by using pencil beam scanning or intensity-modulated proton therapy to target malignant cells with high-energy proton particles. The beam delivery system ensures the proton particles reach the tumor with minimal deviation, reducing the risk of damaging healthy tissues. Healthcare professionals continue to raise awareness about the benefits of proton therapy through campaigns and educational initiatives. In conclusion, proton therapy offers a promising solution for cancer patients seeking effective and precise treatment with minimal side effects. With ongoing advancements in technology and increasing awareness, proton therapy is becoming a preferred choice for treating various types of cancers, including prostate, breast, CNS, and pediatric cancers.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 47% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Proton therapy is an advanced form of radiation therapy that utilizes high-energy proton particles instead of X-ray radiation to destroy cancerous cells. This type of particle therapy offers several advantages over traditional photon therapy, including the ability to deliver precise doses to the tumor while minimizing exposure to healthy tissues. Proton therapy devices consist of an accelerator, beam transport system, beam delivery system, nozzle & image viewers, patient positioning system, and set-up systems. Physicians often recommend proton therapy for various types of cancers, including prostate, breast, CNS, and pediatric cancers. The precision dose delivered by proton therapy reduces the risk of long-term complications compared to X-ray radiation. However, the high cost of proton therapy centers and limited availability have hindered its widespread adoption. Awareness campaigns and collaborations between hospitals and proton therapy centers aim to increase patient access to this innovative therapy. Proton therapy is particularly effective for treating tumors in sensitive areas such as the brain and spinal cord, as it can minimize damage to healthy tissues. The market for proton therapy devices is expected to grow significantly due to the increasing incidence of cancer and the growing awareness of the benefits of proton therapy. Clinical data shows that proton therapy can effectively treat malignant cells caused by cancer-causing viruses and faulty genes. Healthcare professionals are continually researching and developing new technologies, such as pencil beam scanning and intensity-modulated proton therapy, to improve patient outcomes and expand the application of proton therapy.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Proton therapy is an advanced form of radiation therapy that utilizes high-energy proton particles to destroy cancerous cells. This type of therapy is different from traditional photon therapy, which uses X-ray radiation. Proton therapy offers several advantages over photon therapy, including the ability to deliver precise doses to tumors while minimizing damage to healthy tissues. The market is expected to grow significantly due to the increasing incidence of cancer and the growing awareness of the benefits of proton therapy. Proton therapy devices are used in the treatment of various types of cancers, including prostate, breast, CNS, and pediatric cancers. Physicians and healthcare professionals are emphasizing the importance of proton therapy in cancer treatment due to its ability to reduce side effects and long-term complications. Proton therapy centers are being established in hospitals to provide patients with greater access to this advanced form of therapy.
Furthermore, the proton therapy market is driven by the increasing number of clinical data and positive patient outcomes. The market is segmented into various components, including accelerators, beam transport systems, beam delivery systems, nozzles & image viewers, patient positioning systems, and set-up systems. Despite its advantages, proton therapy is not without its challenges. The high cost of proton therapy devices and the complex nature of the technology are major barriers to widespread adoption. Additionally, there are concerns about the potential risks of cancer-causing viruses and faulty genes that could be introduced during the therapy. Awareness campaigns and educational initiatives are being launched to increase understanding of proton therapy and its benefits among patients and healthcare professionals. Innovations in technology, such as pencil beam scanning and intensity-modulated proton therapy, are also driving growth in the market. In conclusion, the market is expected to grow significantly in the coming years due to the increasing incidence of cancer, growing awareness of the benefits of proton therapy, and advancements in technology. Despite the challenges, the potential for precise, effective cancer treatment with minimal side effects makes proton therapy a promising area for investment and innovation.
Proton therapy is an advanced form of radiation therapy that utilizes high-energy beams of protons to target and destroy cancerous cells with pinpoint accuracy. This innovative technology is particularly effective in treating central nervous system cancers, including brain and spinal cord tumors, as well as CNS cancer therapeutics for pediatric oncology patients. The proton therapy market is witnessing significant growth due to the unique advantages it offers over traditional radiation therapy. Rotating proton therapy systems and non-rotating proton therapy systems are two main types of proton therapy systems. The former uses a rotating nozzle to deliver the proton beam, allowing for greater flexibility in treating tumors of various shapes and sizes. In contrast, non-rotating proton therapy systems deliver the beam through a fixed nozzle, making them ideal for treating head and neck cancer and other solid tumors.
By delivering precise doses of radiation directly to the cancerous cells, proton therapy minimizes damage to healthy tissue, reducing side effects and improving patient outcomes. As the demand for effective cancer disorder treatments continues to grow, the proton therapy market is poised for continued expansion, with new technologies and applications driving innovation and progress. In summary, proton therapy is a cutting-edge cancer treatment that utilizes high-energy beams of protons to target and destroy cancerous cells with pinpoint accuracy. Effective in treating central nervous system cancers, pediatric oncology, head and neck cancer, and other cancer disorders, proton therapy offers numerous advantages over traditional radiation therapy, making it a promising solution for the future of cancer care.
Market Scope |
|
Report Coverage |
Details |
Page number |
143 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.51% |
Market growth 2024-2028 |
USD 442.1 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
7.67 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 47% |
Key countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advanced Oncotherapy plc, Elekta AB, Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems Inc., Optivus Proton Therapy Inc., ProTom International Holding Corp., Provision Healthcare, Siemens AG, and Sumitomo Heavy Industries Ltd. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.